PATENT CLAIM ANALYSIS

Application Number: 16114430
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["514", "340000"]

Abstract:
A compound of formula (I) where R 1 , R 2 , X, Y, n, m, R 3 , R 4 , R 5 , R 6  and R 7  are as defined herein, for use in the prophylaxis or treatment of a central and peripheral nervous system disorder, wherein the compound of formula (I) is administered prior to sleep, before bedtime or at bedtime.

Claim (Index 59):
A method for the prophlaxis or treatment of a central and peripheral nervous system disorder, comprising administering to a patient suffering from said disorder between intakes of food, a therapeutically effective amount of a compound of formula (I) as defined in  claim 41 , or its pharmacologically acceptable salts, esters, carbamates and phosphates, in combination with a catecholamine drug, wherein the compound of formula (I) is administered once daily at least one hour after the last daily dose of the catecholamine drug and prior to sleep, before bedtime or at bedtime.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 96.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13963621', '12524848', '12226260', '15757217', '14532925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7314332189203497
- 35 USC 102 Novelty (BERT): 0.5643161504672809
- Combined Prediction Score: 0.7147215120750429
- Mean Citation Score: 282.52888
- Max Citation Score: 508.60254
- Similarity Product: 316.61829973474863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test